Title: DHS Opioid Detection Resilience Act of 2020
Policy area: Crime and Law Enforcement

Summary:
DHS Opioid Detection Resilience Act of 2020
This bill establishes new requirements related to the detection of illicit narcotics at ports of entry.
Specifically, U.S. Customs and Border Protection (CBP) must implement a strategy to ensure chemical screening devices are able to identify narcotics at purity levels equal to or less than 10%, or provide an alternate method for identifying narcotics at lower purity levels. The CBP must also test new chemical screening devices at various purity levels before it commits to their acquisition.
Additionally, the Department of Homeland Security must implement a plan for the long-term development of a centralized spectral database for chemical screening devices.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[S. 3250 Introduced in Senate (IS)]

<DOC>






116th CONGRESS
  2d Session
                                S. 3250

  To ensure U.S. Customs and Border Protection officers, agents, and 
  other personnel have adequate synthetic opioid detection equipment, 
   that the Department of Homeland Security has a process to update 
     synthetic opioid detection capability, and for other purposes.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            February 4, 2020

 Mr. Cornyn (for himself and Ms. Rosen) introduced the following bill; 
which was read twice and referred to the Committee on Homeland Security 
                        and Governmental Affairs

_______________________________________________________________________

                                 A BILL


 
  To ensure U.S. Customs and Border Protection officers, agents, and 
  other personnel have adequate synthetic opioid detection equipment, 
   that the Department of Homeland Security has a process to update 
     synthetic opioid detection capability, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``DHS Opioid Detection Resilience Act 
of 2020''.

SEC. 2. STRATEGY TO ENSURE DETECTION OF ALL OPIOID PURITY LEVELS AT 
              PORTS OF ENTRY.

    Not later than 180 days after the date of the enactment of this 
Act, the Commissioner of U.S. Customs and Border Protection (referred 
to in this section as ``CBP'') shall--
            (1) implement a strategy to ensure deployed chemical 
        screening devices are able to identify in an operational 
        environment narcotics at purity levels less than or equal to 10 
        percent, or provide directors of ports of entry with an 
        alternate method for identifying narcotics at lower purity 
        levels; and
            (2) require testing of any new chemical screening devices 
        to understand the abilities and limitations of such devices 
        relating to identifying narcotics at various purity levels 
        before CBP commits to the acquisition of such devices.

SEC. 3. PLAN TO ENSURE OPIOID DETECTION EQUIPMENT RESILIENCY.

    (a) In General.--Not later than 180 days after the date of the 
enactment of this Act, the Secretary of Homeland Security shall 
implement a plan for the long-term development of a centralized 
spectral database for chemical screening devices.
    (b) Requirements.--The plan required under subsection (a) shall 
address the following:
            (1) How newly identified spectra will be collected, stored, 
        and distributed to such devices in their operational 
        environment, including at ports of entry.
            (2) Identification of parties responsible for updates and 
        maintenance of the centralized spectral database.
                                 <all>